Crestwood Advisors Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.59M | Buy |
22,152
+2,359
| +12% | +$182K | 0.03% | 246 |
|
|
2025
Q4 | $1.57M | Buy |
19,793
+2,274
| +13% | +$179K | 0.03% | 235 |
|
|
2025
Q3 | $1.32M | Sell |
17,519
-646
| -4% | -$44.3K | 0.02% | 255 |
|
|
2025
Q2 | $1.25M | Sell |
18,165
-1,868
| -9% | -$122K | 0.02% | 253 |
|
|
2025
Q1 | $1.36M | Buy |
20,033
+653
| +3% | +$39.1K | 0.03% | 241 |
|
|
2024
Q4 | $870K | Buy |
19,380
+408
| +2% | +$22.9K | 0.02% | 253 |
|
|
2024
Q3 | $1.19M | Sell |
18,972
-1,786
| -9% | -$104K | 0.02% | 219 |
|
|
2024
Q2 | $1.23M | Sell |
20,758
-9,200
| -31% | -$575K | 0.03% | 206 |
|
|
2024
Q1 | $2.39M | Buy |
29,958
+1,163
| +4% | +$88.8K | 0.05% | 157 |
|
|
2023
Q4 | $2.27M | Sell |
28,795
-761
| -3% | -$54.2K | 0.05% | 154 |
|
|
2023
Q3 | $2.06M | Buy |
29,556
+21,058
| +248% | +$1.49M | 0.05% | 150 |
|
|
2023
Q2 | $587K | Sell |
8,498
-204,868
| -96% | -$14.6M | 0.02% | 173 |
|
|
2023
Q1 | $15.9M | Sell |
213,366
-8,301
| -4% | -$696K | 0.53% | 57 |
|
|
2022
Q4 | $20.7M | Sell |
221,667
-4,433
| -2% | -$428K | 0.7% | 48 |
|
|
2022
Q3 | $21.6M | Sell |
226,100
-16,493
| -7% | -$1.63M | 0.77% | 48 |
|
|
2022
Q2 | $22.5M | Sell |
242,593
-42,777
| -15% | -$4.17M | 0.76% | 50 |
|
|
2022
Q1 | $28.9M | Sell |
285,370
-114,784
| -29% | -$12.1M | 0.81% | 44 |
|
|
2021
Q4 | $41.3M | Buy |
400,154
+11,652
| +3% | +$1.08M | 1.07% | 35 |
|
|
2021
Q3 | $33M | Buy |
388,502
+2,581
| +0.7% | +$216K | 0.93% | 44 |
|
|
2021
Q2 | $32.2M | Buy |
385,921
+5,338
| +1% | +$437K | 0.93% | 41 |
|
|
2021
Q1 | $28.6M | Buy |
380,583
+23,788
| +7% | +$1.73M | 0.9% | 43 |
|
|
2020
Q4 | $24.4M | Sell |
356,795
-52,901
| -13% | -$3.44M | 0.8% | 50 |
|
|
2020
Q3 | $23.9M | Buy |
409,696
+2,776
| +0.7% | +$173K | 0.9% | 43 |
|
|
2020
Q2 | $26.4M | Buy |
406,920
+21,297
| +6% | +$1.34M | 1.06% | 35 |
|
|
2020
Q1 | $22.9M | Buy |
385,623
+714
| +0.2% | +$47.7K | 1.14% | 35 |
|
|
2019
Q4 | $28.6M | Buy |
384,909
+54,014
| +16% | +$3.79M | 1.13% | 33 |
|
|
2019
Q3 | $20.9M | Buy |
330,895
+64,579
| +24% | +$3.83M | 0.92% | 45 |
|
|
2019
Q2 | $14.5M | Buy |
266,316
+21,640
| +9% | +$1.17M | 0.66% | 56 |
|
|
2019
Q1 | $13.2M | Buy |
244,676
+25,942
| +12% | +$1.6M | 0.95% | 45 |
|
|
2018
Q4 | $14.3M | Sell |
218,734
-11,491
| -5% | -$858K | 1.14% | 42 |
|
|
2018
Q3 | $18.1M | Sell |
230,225
-2,027
| -0.9% | -$145K | 1.27% | 36 |
|
|
2018
Q2 | $16.1M | Sell |
232,252
-1,787
| -0.8% | -$118K | 1.17% | 40 |
|
|
2018
Q1 | $14.6M | Buy |
234,039
+35,606
| +18% | +$2.55M | 1.14% | 39 |
|
|
2017
Q4 | $14.4M | Sell |
198,433
-40,009
| -17% | -$2.91M | 1.14% | 39 |
|
|
2017
Q3 | $19.4M | Buy |
238,442
+1,760
| +0.7% | +$139K | 1.66% | 22 |
|
|
2017
Q2 | $18.9M | Buy |
236,682
+12,234
| +5% | +$966K | 1.61% | 26 |
|
|
2017
Q1 | $17.7M | Buy |
+224,448
| New | +$17.9M | 1.56% | 26 |
|
|
2016
Q4 | – | Sell |
-4,464
| Closed | -$397K | – | 165 |
|
|
2016
Q3 | $397K | Sell |
4,464
-540
| -11% | -$51K | 0.05% | 86 |
|
|
2016
Q2 | $479K | Sell |
5,004
-2,000
| -29% | -$199K | 0.06% | 81 |
|
|
2016
Q1 | $727K | Sell |
7,004
-6,300
| -47% | -$613K | 0.09% | 75 |
|
|
2015
Q4 | $1.3M | Buy |
13,304
+1
| +0% | +$98 | 0.16% | 62 |
|
|
2015
Q3 | $1.28M | Buy |
13,303
+1
| +0% | +$105 | 0.17% | 58 |
|
|
2015
Q2 | $1.4M | Buy |
13,302
+8,955
| +206% | +$915K | 0.19% | 54 |
|
|
2015
Q1 | $449K | Buy |
+4,347
| New | +$440K | 0.06% | 86 |
|
|
2014
Q1 | – | Sell |
-5,807
| Closed | -$416K | – | 119 |
|
|
2013
Q4 | $416K | Sell |
5,807
-803
| -12% | -$51.6K | 0.07% | 82 |
|
|
2013
Q3 | $375K | Buy |
6,610
+170
| +3% | +$10.1K | 0.07% | 86 |
|
|
2013
Q2 | $368K | Buy |
+6,440
| New | +$373K | 0.07% | 89 |
|
Other funds holding CVS
VCM
VPM
Crestwood Advisors Group's CVS Position: Q1 2026 in Review
Crestwood Advisors Group increased its CVS Health (CVS) stake by 12% in Q1 2026, buying an estimated $182K and bringing the position to 22,152 shares worth $1.59M. The position accounts for 0.03% of the portfolio, ranked #246.
Crestwood Advisors Group first reported a position in CVS in Q2 2013 and has held it in 47 quarters since. The position peaked at $41.3M in Q4 2021. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Crestwood Advisors Group held 22,152 shares of CVS Health worth $1.59M as of Q1 2026.
- Crestwood Advisors Group bought 2,359 CVS Health shares in Q1 2026, an estimated $182K.
- CVS Health made up 0.03% of Crestwood Advisors Group's portfolio in Q1 2026, its #246 holding.
- Crestwood Advisors Group first reported a position in CVS Health in Q2 2013 and has held it in 47 quarters since.
- Crestwood Advisors Group's CVS Health position peaked at $41.3M in Q4 2021.
- 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Crestwood Advisors Group's 13F filing for Q1 2026, filed 5 May 2026.